These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12173490)

  • 1. A clinical armamentarium of marine-derived anti-cancer compounds.
    Jimeno JM
    Anticancer Drugs; 2002 May; 13 Suppl 1():S15-9. PubMed ID: 12173490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of marine-derived anti-cancer compounds].
    Taguchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):579-88. PubMed ID: 12795086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kahalalide F and ES285: potent anticancer agents from marine molluscs.
    Faircloth G; Cuevas C
    Prog Mol Subcell Biol; 2006; 43():363-79. PubMed ID: 17153351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development and acquisition of anticancer agents from marine sources.
    Amador ML; Jimeno J; Paz-Ares L; Cortes-Funes H; Hidalgo M
    Ann Oncol; 2003 Nov; 14(11):1607-15. PubMed ID: 14581267
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in the clinical development of new marine-derived anticancer compounds.
    Jimeno J; López-Martín JA; Ruiz-Casado A; Izquierdo MA; Scheuer PJ; Rinehart K
    Anticancer Drugs; 2004 Apr; 15(4):321-9. PubMed ID: 15057135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ET-743 (PharmaMar/NCI/Ortho Biotech).
    Verschraegen CF; Glover K
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells.
    Gómez SG; Bueren JA; Faircloth GT; Jimeno J; Albella B
    Exp Hematol; 2003 Nov; 31(11):1104-11. PubMed ID: 14585376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor compounds from tunicates.
    Rinehart KL
    Med Res Rev; 2000 Jan; 20(1):1-27. PubMed ID: 10608919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some hope from marine natural products.
    D'Incalci M
    Ann Oncol; 1998 Sep; 9(9):937-8. PubMed ID: 9818065
    [No Abstract]   [Full Text] [Related]  

  • 10. Convergent approaches for the synthesis of the antitumoral peptide, Kahalalide F. Study of orthogonal protecting groups.
    Gracia C; Isidro-Llobet A; Cruz LJ; Acosta GA; Alvarez M; Cuevas C; Giralt E; Albericio F
    J Org Chem; 2006 Sep; 71(19):7196-204. PubMed ID: 16958512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
    Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
    Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
    Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
    Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the studies on antitumor natural product ecteinascidin-743].
    Wang Y; Liu ZZ; Chen SZ; Liang XT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):474-8. PubMed ID: 15379280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advance of several types of important marine antitumor drugs].
    Zhang JY; Fu LW
    Yao Xue Xue Bao; 2008 May; 43(5):435-42. PubMed ID: 18717327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B.
    Tsukimoto M; Nagaoka M; Shishido Y; Fujimoto J; Nishisaka F; Matsumoto S; Harunari E; Imada C; Matsuzaki T
    J Nat Prod; 2011 Nov; 74(11):2329-31. PubMed ID: 22035372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.
    Nuijen B; Bouma M; Henrar RE; Manada C; Bult A; Beijnen JH
    Anticancer Drugs; 1999 Nov; 10(10):879-87. PubMed ID: 10630355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison.
    Le Tourneau C; Raymond E; Faivre S
    Curr Pharm Des; 2007; 13(33):3427-39. PubMed ID: 18045196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs from the sea.
    D'Incalci M; Simone M; Tavecchio M; Damia G; Garbi A; Erba E
    J Chemother; 2004 Nov; 16 Suppl 4():86-9. PubMed ID: 15688619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications.
    Lee Y; Phat C; Hong SC
    Peptides; 2017 Sep; 95():94-105. PubMed ID: 28610952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F.
    Sparidans RW; Stokvis E; Jimeno JM; López-Lázaro L; Schellens JH; Beijnen JH
    Anticancer Drugs; 2001 Aug; 12(7):575-82. PubMed ID: 11487713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.